The following items were approved:
-
Adoption of the Financial Statements for 2012
-
Adoption of the dividend for 2012 (see also separate press release)
-
Release from liability of the members of the Managing Board and Supervisory Board for their responsibilities in the financial year 2012
-
Appointment of Mr. D. de Vreeze as a member of the Managing Board
-
Reappointment of Mr. P. Hochuli as a member of the Supervisory Board
-
Adjustment of the remuneration policy for the Managing Board
-
Extension of the period during which the Managing Board is authorized to issue ordinary shares and to limit or exclude the preferential right when issuing ordinary shares
-
Authorization of the Managing Board to have the company repurchase shares
-
Reduction of the issued capital by canceling shares
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 23,500 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext.
More information can be found at www.dsm.com (http://www.dsm.com/).
For more information:
DSM Corporate CommunicationsHerman Bettentel. +31 (0) 45 5782017 e-mail media.relations@dsm.com (mailto:media.relations@dsm.com) | DSM Investor RelationsDave Huizingtel. +31 (0) 45 5782864 fax +31 (0) 10 4590275 e-mail investor.relations@dsm.com (mailto:investor.relations@dsm.com) |
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
